Loading page content…
Loading page content…
The UK Health Security Agency (UKHSA) is inviting suppliers to participate in this pre-market engagement exercise for the Lateral Flow Device (LFD) pilot and development activity. This work supports UKHSA’s broader strategy to strengthen the UK’s ability to understand, prevent, and respond to health threats, as set out in the UKHSA Strategy 2026–2029. It also aligns with the UK’s commitment to the 100 Days Mission, which aims to enable the rapid development and deployment of diagnostics, therapeutics, and vaccines within 100 days of identifying a new pandemic threat. A key objective of this programme is to develop resilient, scalable UK-based manufacturing capability for LFDs, reducing reliance on international supply chains and improving national biosecurity. For the purposes of this exercise, UK-based manufacturing refers to the ability to undertake core stages of assay development, device manufacture, and final assembly within the UK, supported by a robust and scalable supply chain. Suppliers are not required to have a fully domestic supply chain but must demonstrate transparency, resilience, and the ability to sustain production at scale during an outbreak. LFDs, particularly a
BidWriter drafts your responses from your company profile, scores them against the marking scheme, and tracks your whole pipeline. Free to start — no card needed.
Start free →